UNITED STATES OF AMERICA
Before the
SECURITIES AND EXCHANGE COMMISSION
February 11, 2000
________________________________
:
Wellness Universe, Inc. : ORDER OF SUSPENSION
: OF TRADING
File No. 1-500 :
________________________________:
It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of Wellness Universe, Inc. ("Wellness") because of questions about the accuracy and adequacy of publicly disseminated information concerning, among other things: the business prospects of Wellness and Synpan Corporation ("Synpan"), a related entity; the employment of Synpan officers; and a purportedly planned initial public offering of Synpan securities.
The Commission is of the opinion that the public interest and the protection of investors require a suspension of trading in the securities of the above listed company.
Therefore, it is ordered, pursuant to Section 12(k) of the Securities Exchange Act of 1934, that trading in the above listed company is suspended for the period from 9:30 a.m. EST, on February 11, 2000 through 11:59 p.m. EST, on February 25, 2000.
By the Commission.
Jonathan G. Katz
Secretary
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
SECURITIES EXCHANGE ACT OF 1934
Release No. 42414 / February 11, 2000
The Securities and Exchange Commission announced the temporary suspension, pursuant to Section 12(k) of the Securities Exchange Act of 1934 ("Exchange Act"), of trading in the securities of Wellness Universe, Inc. ("Wellness") of Minnesota at 9:30 a.m. EST on February 11, 2000 and terminating at 11:59 p.m. EST on February 25, 2000.
The Commission temporarily suspended trading in the securities of Wellness because of questions about the accuracy and adequacy of publicly disseminated information concerning, among other things: the business prospects of Wellness and Synpan Corporation ("Synpan"), a related entity; the employment of Synpan officers; and a purportedly planned initial public offering of Synpan securities.
The Commission cautions broker-dealers, shareholders, and prospective purchasers that they should carefully consider the foregoing information along with all other currently available information and any information subsequently issued by the company.
Further, brokers and dealers should be alerted to the fact that, pursuant to Rule 15c2-11 under the Exchange Act, at the termination of the trading suspension, no quotation may be entered unless and until they have strictly complied with all the provisions of the rule. If any broker or dealer has any questions as to whether or not he has complied with the rule, he should not enter any quotation but immediately contact the staff of the Securities and Exchange Commission in Washington, D.C. If any broker or dealer is uncertain as to what is required by Rule 15c2-11, he should refrain from entering quotations relating to Wellness' securities until such time as he has familiarized himself with the rule and is certain that all of its provisions have been met. If any broker or dealer enters any quotation that is in violation of the rule, the Commission will consider the need for prompt enforcement action.
If any broker-dealer or other person has any information that may relate to this matter, the Northeast Regional Office of the Securities and Exchange Commission should be telephoned at (212) 748-8186. |
